Dr. Charles Turck and Dr. Maryam Lustberg Discuss What's Ahead in HER2-low breast cancer

Addressing Unmet Needs in HER2-Low Breast Cancer Care  

Addressing Unmet Needs in HER2-Low Breast Cancer Care
RestartResume

Explore the treatment landscape, therapeutic challenges and limitations, and the resultant unmet needs for patients with HER2-low breast cancer. 

  • Overview

    Amid the evolving treatment landscape for HER2-low breast cancer, many therapeutic challenges and limitations remain, resulting in unmet needs for our patients. Fortunately, developments in the therapeutic landscape can help address those unmet needs, and joining Dr. Charles Turck to share what’s on the horizon is Dr. Maryam Lustberg.

Facebook Comments

NEW FEATURES:

Register

We’re glad to see you’re enjoying Global Oncology Academy…
but how about a more personalized experience?

Register for free